Market News
Smart Trading. Simplified.
Small Biotech Could Soar 1,000%
There's no sector poised to deliver bigger gains in 2021 than small-cap biotech stocks.
In the past year alone...
Novavax Inc jumped from $6.26 to $270.51, a gain of 3,396%.
Aclaris Therapts jumped from $0.70 to $24.28 an increase of 1,583%.
Vaxart Inc rocketed from $0.97 to $14.94, a 1,083% jump.
Here's the next biotech we think could soar 1,000% >>>
Sea Limited Stock Forecast
Sea Limited Stock Forecast: Sea Limited is a Singapore-based leading internet platform providing digital entertainment, electronic commerce, and digital financial service businesses in Singapore, Thailand, Latin America, rest of Asia, and internationally. The company operates through three segments: Digital entertainment, E-commerce, and Digital financial services. It generates the bulk of its revenue from the Digital […]
Former Broker Dealer Teaches Traders...
"If I had a stadium filled with my former students, I'd teach them how to spot and trade within Vomma Zone."
Don Kaufman, 23-Year Professional Trader and Educator at TD Ameritrade, shares it all.
Join Don as he breaks down this special zone he calls the "Vomma Zone."
Watch him share the exact playbook he uses to extract consistent profits from an increasingly volatile market.
How High Can GE Stock Go?
General Electric Company (NYSE:GE) is a multinational conglomerate based in Boston, Massachusetts. It’s involved in a variety of industries, including healthcare, aviation, and additive manufacturing. GE share price suffered over the last decade, but current CEO Lawrence Culp is on a roll bringing the company back. GE stock is on the rise while the airlines […]
New "Trojan Horse" Treatment Could Cost $2 Million
The New York Times reports new treatment "will change medicine."
Wall Street thinks it could be a $2 TRILLION market worldwide.
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>>
Cardano Vs Ethereum: Which Is Best?
Cardano Vs Ethereum: Crypto fans have a lot of options – specifically, though, they have two big names in cutting-edge smart contract blockchains to think about. Ethereum and Cardano are both big movers in the crypto space right now, and they have a specific relationship to each other that you should know about if you’re […]
The World's First $2 Trillion Drug?
The Wall Street Journal reports new treatment is "transforming medicine."
Bill Gates writes that it could "help humanity."
Ark Investments think it could be a "$2 trillion market."
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>>
How High Can Google Go?
Google’s parent company Alphabet Inc (NASDAQ:GOOGL) is one of the most valuable and successful companies in the world. It’s an advertising juggernaut that owns a large portion of online search. The company is worth over $1.5 trillion and is poised to keep growing, but how high can Google go? Alphabet turned in great earnings reports […]
Gold's Dramatic Rise is Creating a Brand New Batch of Multi-Millionaires
Biden's $6 Trillion spending spree is driving gold toward all-time highs. The Smart Money is flowing into a newly-listed $5 gold stock that brilliantly receives a cut of global gold production without any of the risks, or costs, of operating a mine.
Where Can I Buy DeFi Pulse Index?
While it might look exceptionally complex on the surface, the traditional banking system operates on one elementary principle: It accepts money from depositors, and then lends those funds to borrowers. Banks operate as intermediaries between depositors and borrowers, facilitating the process of matching funds with creditworthy consumers. Banks pay depositors interest, and they charge borrowers […]
Discover The Secrets To Low-Risk, High-Reward Options Trades!
Join Danielle Shay (Director of Options at Simpler Trading) and stock market expert Marc Chaikin, for a live options trading event! You'll find out how she built an extraordinary trading account and manages to find high-probability setups over and over again-and how you can, too! It's called the Finding Phoenix Method.
Click here to register now before this event fills up!
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment